- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06556901
Management of Patients Who Claim to be Electrosensitive (IEI CEM EN MED)
August 13, 2024 updated by: University Hospital, Brest
Evaluation of the Feeling of General Practitioners in the Management of Patients Who Claim to be Electrosensitive
Know qualitatively the ways to deal with these patients, in general medicine in Brittany, and the difficulties encountered, through thematic and lexicometric analysis of responses
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Ministry of Health instructed the French society of medicine work (Dr Pougnet for the Brest CHRU) to coordinate the drafting of practical guides for the management of people claiming to have IEI-CEM (Intolerance Environmental Idiopathic in the Fields ElectroMagnetic) for care physicians primary (general practitioners).
To meet this mission, it is necessary to know qualitatively the difficulties encountered by general practitioners during the management of these people.
Study Type
Observational
Enrollment (Actual)
1400
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brest, France, 29609
- CHRU de Brest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Population of general practitioners practicing in Brittany in 2018.
Population assessed by the ODM between 3000 and 3200 liberal general practitioners
Description
Inclusion Criteria: The inclusion criteria will be to be general practitioners, to have practiced between 01/01/2018 and 12/31/2018.
Exclusion Criteria:
- be other practionners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
principal
Time Frame: 2 years
|
The main endpoint is to have taken care of a patient who claims to have electromagnetic sensibility.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
June 1, 2021
Study Completion (Actual)
September 1, 2021
Study Registration Dates
First Submitted
June 4, 2021
First Submitted That Met QC Criteria
August 13, 2024
First Posted (Actual)
August 16, 2024
Study Record Updates
Last Update Posted (Actual)
August 16, 2024
Last Update Submitted That Met QC Criteria
August 13, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 29BRC19.0155
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electromagnetic Field
-
Cairo UniversityNot yet recruitingBurns | Whole Body Vibration | Pulsed Electromagnetic FieldEgypt
-
Taipei Medical UniversityUnknownFatigue | Stress | Sleep Quality | Extremely Low Frequency Electromagnetic Field Device | Schumann ResonanceTaiwan
-
Cairo UniversityCompletedDysmenorrhea | Electromagnetic Field
-
Edward-Elmhurst Health SystemCompletedElectromagnetic InterferenceUnited States
-
University Hospital, GenevaCompletedElectromagnetic InterferenceSwitzerland
-
Maisonneuve-Rosemont HospitalCompletedElectromagnetic Interference
-
Deutsches Herzzentrum MuenchenCompletedElectromagnetic InterferenceGermany, Greece
-
Clinique BizetCompletedElectromagnetic Emissions and Emotional Disorder | Electromagnetic Emissions and Medication SavingsFrance
-
Deutsches Herzzentrum MuenchenBayerisches Staatsministerium für Wirtschaft; R & S GmbH und Co KGCompletedElectromagnetic InterferenceGermany
-
Deutsches Herzzentrum MuenchenCompletedElectromagnetic InterferenceGermany
Clinical Trials on retrospective study about reasons for consultations
-
Erasmus Medical CenterCompletedCoronary Artery Disease
-
Central Hospital, Nancy, FranceCompleted
-
Poitiers University HospitalCompletedPostnatal DepressionFrance
-
Universidad de ExtremaduraCompletedPain | Foot Diseases | MetatarsalgiaSpain
-
Rennes University HospitalRecruitingHysterectomies for Low- or Intermediate-risk Endometrial CarcinomaFrance
-
National Cancer Institute (NCI)CompletedB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia